Clinical Study

Role of FNA and Core Biopsy of Primary and Metastatic Liver Disease

Table 2

Features of the equivocal cases.

CaseAFPCirrhosisCTDiagnosisFNACore

16.6CI (classic)RFA-alive1None
249B + CIII equivocalExpired HCC2 None
314.6C + ETOHIII equivocalProgression1, 13
4241CI (classic)Path proven HCC-surgery3None
54.1BI (classic)Path proven HCC-surgery4 None
63.6CI (classic)Path proven HCC-surgery62
71.8None III equivocalAdenoma44
85CIII equivocalPath proven HCC-surgery3, 77, 7, 7
9None ETOHII infiltration Died HCC5None
1014,044CII infiltration Hospice HCC1, 3 7
11149ETOH I (classic)Path proven HCC-surgery. RFA transplant47
126.4NoneIII equivocalProgression74
1319.5CI (classic)Lost to follow-up47

1: atypical hepatocyte; 2: HCC versus METS; 3: HCC versus regenerating nodules; 4: HCC versus adenoma; 5: inadequate; 6: abscess; 7: no malignancy. Equivocal cases including Alpha Fetoprotein (AFP) values and presence of cirrhosis including etiology for example hepatitis C (C), hepatitis B (B), or alcohol (ETOH). The review of CT results, patient follow-up and classification of results from the cytology or histology report.